Clinical trial NCT06116058: Integrated Neuromuscular Inhibition Versus Instrument Assisted Soft Tissue Mobilization in Chronic Back Pain
Official title: Integrated Neuromuscular Inhibition Technique Versus Instrument Assisted Soft Tissue Mobilization in Patients With Chronic Non Specific Low Back Pain
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Chronic Non Specific Low Back Pain
Keywords: chronic non specific low back pain
integrated nouromuscular inhibition technique
instrument assisted soft tissue mobilization technique
Lead sponsor: Cairo University
Sponsor class: OTHER
First posted: 2023-11-03
Enrollment: 45
Sex: ALL
Minimum age (years): 18
Maximum age (years): 30
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: 1. integrated neuromuscular inhibition technique and conventional physical therapy
2. instrument assisted soft tissue mobilization technique and conventional physical therapy
3. conventional physical therapy only
Primary purpose: TREATMENT

Brief summary: this study will be conducted to identify the difference between the effect of integrated neuromuscular inhibition technique and instrument assisted soft tissue mobilization on back pain, pain threshold, back rang of motion ,back proprioception and back disability in chronic non specific low back pain


Eligibility criteria: Inclusion Criteria:

* 1. The patient's age ranged from 18 to 30 years.(Geogre et al, 2021) 2. Patients with low back pain for more than 3 months (pain felt between T12 and the gluteal fold).

  3. Patient with chronic low back pain 4. Normal body mass index from 18 -25kg/m2.

Exclusion Criteria:

* The subjects will be excluded if they have any of the followings:

  1. Lumbar discogenic lesions or any inflammatory arthritis, tumors, infection involving the lumbar spine.
  2. Patients with decreased range of motion secondary to congenital anomalies, muscular contracture, or bony block.
  3. Previous lumbar or hip surgery or trauma.
  4. Any hip structural abnormality such as malformations, impingements and degeneration.
  5. Patients With cognitive impairments that would limit their participation

Primary outcomes:
measure: change in lumber proprioception
timeFrame: Evaluation will be performed priod to the first treatment session :as a baseline measure,and at least treatment session (after 4 weeks)as a post-treatment measure
measure: chang in pain pressure threshold
timeFrame: Evaluation will be performed priod to the first treatment session :as a baseline measure,and at least treatment session (after 4 weeks)as a post-treatment measure
Secondary outcomes:
measure: chang in lumbar rang of motion(ROM)
timeFrame: Evaluation will be performed priod to the first treatment session :as a baseline measure,and at least treatment session (after 4 weeks)as a post-treatment measure
measure: functional disability oFlumbar spine
timeFrame: Evaluation will be performed priod to the first treatment session :as a baseline measure,and at least treatment session (after 4 weeks)as a post-treatment measure
measure: pain level of lumbar spine
timeFrame: Evaluation will be performed priod to the first treatment session :as a baseline measure,and at least treatment session (after 4 weeks)as a post-treatment measure
Other outcomes:
Locations:
Study officials:
References: